-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

DEI in Clinical Trials - Perceived Versus Actual Barriers and How to Address Them: Industry Perspective

Scientific Workshop on Defining Goals and Utilizing Tools for Enhancing Diversity, Equity and Inclusion (DEI) in Clinical Trials in Hematology
Program: Scientific Workshops
Session: Current State and Anticipated Barriers in Increasing DEI in Hematology Clinical Trials
Friday, December 8, 2023, 2:05 PM-3:00 PM

Ahmed Abd Almalik Daak, MD, PhD, MSc, DPM/MFPM

Clinical Development- Rare Blood Disorders, Sanofi, Concord, MA

Disclosures: Daak: Sanofi: Current Employment, Current equity holder in publicly-traded company.

See more of: Current State and Anticipated Barriers in Increasing DEI in Hematology Clinical Trials
See more of: Scientific Workshop on Defining Goals and Utilizing Tools for Enhancing Diversity, Equity and Inclusion (DEI) in Clinical Trials in Hematology
See more of: Scientific Workshops
<< Previous Presentation | Next Presentation